文献速递糖尿病肥胖与代谢综合征

治疗妊娠期糖尿病可降低出生体重但不影响婴儿第一年肥胖度

Treating Gestational Diabetes Reduces Birth Weight but Does Not Affect Infant Adiposity Across the 1st Year of Life.
PubMed 文献 · Diabetes Care · 2022-01-01

本研究纳入567名婴儿,按母亲孕期葡萄糖耐受情况分四组,比较3月龄和12月龄人体测量指标。治疗妊娠期糖尿病组出生体重最低、巨大儿率最低,但四组在3月龄和12月龄的体重、身长、体重身长比、BMI的z评分及皮褶厚度均无显著差异。结论认为治疗妊娠期糖尿病虽降低出生体重和巨大儿率,但不影响婴儿第一年肥胖度。

要点

  • 治疗妊娠期糖尿病组出生体重最低(P=0.0004),巨大儿率也最低(P=0.02)。
  • 四组婴儿在3月龄和12月龄的体重、身长、体重身长比、BMI的z评分均无显著差异。
  • 四组婴儿在3月龄和12月龄的皮褶厚度及皮褶总和均无显著差异。

核心结论

  • 治疗妊娠期糖尿病虽降低出生体重和巨大儿率,但对婴儿第一年肥胖度无类似影响。

研究设计与样本

  • 研究纳入567名婴儿,其母亲按孕期葡萄糖耐受情况分为四组:葡萄糖挑战试验(GCT)和口服葡萄糖耐量试验(OGTT)均正常组、GCT异常但OGTT正常组、轻度妊娠期糖耐量受损组、接受治疗的妊娠期糖尿病组。
  • 在婴儿3月龄和12月龄时进行人体测量学检查。

主要发现

  • 出生体重在三个未治疗组中逐渐升高,但在治疗妊娠期糖尿病组中最低(P=0.0004)。
  • 治疗妊娠期糖尿病组的巨大儿率最低(P=0.02)。
  • 四组在3月龄和12月龄的体重z评分、身长z评分、体重身长比z评分、BMI z评分均无显著差异(所有P值=NS)。
  • 四组在3月龄和12月龄的三头肌/二头肌/肩胛下/髂上皮褶厚度及皮褶总和均无显著差异(所有P值=NS)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The continuum of maternal glycemia in pregnancy shows continuous associations with both 1) neonatal birth weight at delivery and 2) subsequent adiposity later in childhood. While treating gestational diabetes mellitus (GDM) can lower birth weight and thereby disrupt the former association, it is unclear if such treatment reduces childhood adiposity. Thus, we sought to compare anthropometry across the 1st year of life between infants born to women who were treated for GDM and those with lesser degrees of gestational dysglycemia (untreated). RESEARCH DESIGN AND METHODS: Anthropometric measurements were performed at 3 months and 12 months of life in 567 infants born to women comprising the following four gestational glucose tolerance groups: 1) women with normoglycemia on both glucose challenge test (GCT) and oral glucose tolerance test (OGTT) in pregnancy; 2) women with an abnormal GCT but normal OGTT; 3) those with mild gestational impaired glucose tolerance; and 4) women treated for GDM. RESULTS: Birth weight progressively increased across the three untreated groups but was lowest in women treated for GDM (P = 0.0004). Similarly, women treated for GDM had the lowest rate of macrosomia (P = 0.02). Conversely, however, there were no differences among the four groups in weight z score, length z score, weight-for-length z score, or BMI z score at either 3 months or 12 months (all P values = NS). Similarly, there were no differences among the groups in triceps/biceps/subscapular/suprailiac skinfold thickness or sum of skinfolds at either 3 months or 12 months (all P values = NS). CONCLUSIONS: Despite reducing birth weight and macrosomia, the treatment of GDM does not have analogous effects on infant adiposity across the 1st year of life.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Retnakaran R, Ye C, Hanley AJ, et al. Treating Gestational Diabetes Reduces Birth Weight but Does Not Affect Infant Adiposity Across the 1st Year of Life. Diabetes Care. 2022. PMID: 35259243. doi:10.2337/dc21-2640

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。